1. MARKETS
  2. SECTOR : HEALTHCARE & MEDICAL EQUIPMENT SUPPLIERS
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. PROFOUND MEDICAL CORP
Profound Medical Corp
XNAS: PROF
Download real time
6.90-0.01(-0.14%)
43.75% Gain from 52W Low
419.9K
XNAS Volume
High vol.+gain this week

XNAS 09 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

Profound Medical Corp quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Profound Medical Corp share price target, revenues, EPS, net income and more

Profound Medical Corp quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
  • POSITIVE

    Quarterly Revenue Profound Medical Corp Jun-2026 Quarterly Revenue is $2 Million which is growth of 12.3% YoY.

  • POSITIVE

    Quarterly Net Profit Profound Medical Corp Jun-2026 Quarterly Net Profit is $-10 Million which is growth of 39.2% YoY.

Profound Medical Corp, Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23
Operating Rev.
2.55.365.32.22.63.72.82.21.921.71.6
Cost Of Rev.
0.51.521.40.60.81.210.80.610.70.6
Gross Profit
23.843.91.61.92.51.81.41.31.11.11.1
⌄
1311.911.412.815.41311.310.89.38.89.87.67.5
Operating Profit
-11.1-8-7.4-8.9-13.8-11.2-8.8-9-7.8-7.5-8.8-6.6-6.4
⌄
0.30.40.20.10.30.5-0.6-0.20.91.30.510.3
Profit Before Tax
-9.5-7-8.2-7.9-15.6-10.7-5.6-9.2-6.9-6.2-9.1-5.6-7.3
Tax
0.1000.10.10-0.20.200-0.200
⌄
-9.5-7.1-8.2-8-15.7-10.7-5.3-9.4-6.9-6.2-8.9-5.6-7.4
Diluted NI Avail to Com Stockholders Ann.
-9.5-7.1-8.2-8-15.7-10.7-5.3-9.4-6.9-6.2-8.9-5.6-7.4
Basic EPS
-0.3-0.2-0.3-0.3-0.5-0.4-0.2-0.4-0.3-0.3-0.4-0.3-0.4
Diluted EPS After ExtraOrdinary
-0.3-0.2-0.2-0.3-0.5-0.4-0.2-0.4-0.3-0.3-0.4-0.3-0.3
Number Of Shares End
36.436.330.630.130.13025.824.624.723.821.321.421.2
Net Income Continuing Discontinued Operations
-9.5-7.1-8.2-8-15.7-10.7-5.3-9.4-6.9-6.2-8.9-5.6-7.4
Normalized Income
-8.8-6.2-7-6.6-14.5-9.9-4.9-8.9-6.3-5.6-8-5-6.5
Interest Income
----------1.410.5
Interest
-------0.2----0.2
Net Interest Income
0.30.40.20.10.30.5-0.6-0.20.91.30.510.3
EBIT
-9.8-7.4-8.3-8-16-11.1-5-9-7.8-7.5-9.7-6.6-7.6
EBITDA
-9.7-7.3-8.2-7.8-15.8-11-4.9-8.7-7.6-7.2-9.4-6.3-7.3
Reconciled Cost Of Rev.
0.51.521.40.60.81.210.80.610.70.6
Reconciled Depr.
0.10.10.10.20.10.20.10.30.30.30.30.30.3
Profit From Continuing Operations
-9.5-7.1-8.2-8-15.7-10.7-5.3-9.4-6.9-6.2-8.9-5.6-7.4
Normalized EBITDA
-12.2-8.5-6.3-9.7-11.5-11-8.7-8.7-7.6-7.2-7.8-6.3-5.7
*All financials are in USD Million and price data in USD
Add metric to table
Search...

Profound Medical Corp competitor comparison and performance snapshot within industry

Profound Medical Corp annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Annual Revenue Profound Medical Corp Dec-2025 Annual Revenue is $16 Million which is growth of 50.7% YoY.

  • NEGATIVE

    Annual Net Profit Profound Medical Corp Dec-2025 Annual Net Profit is $-43 Million which is growth of -53.0% YoY.

Profound Medical Corp, Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
⌄
33.9%
17.1%
 16.110.77.26.76.97.34.21.93.9
Cost Of Rev. Ann.
8.3%
4.3%
5.44.73.62.83.73.93.81.81.32.4--
Gross Profit Ann.
56%
26.6%
13.711.474.4333.52.40.61.5--
Operating Exp. Ann.
17.4%
18.8%
49.152.740.13332.633.222.317.615.415.511.68.1
Operating Profit Ann.
-
-
-35.4-41.3-33.1-28.6-29.6-30.3-18.9-15.1-14.8-14-11.6-8.1
⌄
6.9%
40.6%
11.11.40.70.9-0.30.2-0.7-0.4-1-0.5-5.4
Other Exp. Ann.
-
-
 -2.13.8-0.80.30-2.90.50.20.1-1.2
PBT Ann.
-
-
-32.5-42.3-27.8-28.7-28.4-30.6-21.6-15.3-15.1-14.9-12.1-12.3
Tax Ann.
0%
-
0.20.3-0.10.30.100.20.20.10-0.5
⌄
-
-
-32.7-42.6-27.8-28.6-28.7-30.7-21.6-15.5-15.2-15-12.2-11.8
Diluted NI Avail to Com Stockholders Ann.
-
-
-32.7-42.6-27.8-28.6-28.7-30.7-21.6-15.5-15.2-15-12.2-11.8
EPS Ann.
-
-
 -1.4-1.1-1.4-1.4-1.5-1.3-1.4-1.6-2.4-2.9-5.4
Diluted EPS Ann.
-
-
 -1.4-1.1-1.4-1.4-1.5-1.3-1.4-1.6-2.4-2.9-5.4
Number Of Shares End
13.6%
9.2%
 30.625.821.320.920.819.711.910.87.34.84
Total Exp. Ann.
16.5%
17%
 57.443.735.836.337.226.219.416.717.911.68.1
Net Income Continuing Discontinued Operations Ann.
-
-
-32.7-42.6-27.8-28.6-28.7-30.7-21.6-15.5-15.2-15-12.2-11.8
Normalized Income Ann.
-
-
-28.5-37.9-25.2-24.9-22.8-25.6-19.2-14.7-15.6-13.7-11.8-13.9
Interest Income Ann.
-
-
 --1.60.80.20.70.40.40.10.10.1
Interest Ann.
-
-
 --0.80.20.10.51.10.81.10.64.1
EBITDA Ann.
-
-
-33-42.8-28.3-28.4-27.4-28.9-20.2-12.9-14.1-12.8-11.7-9
Reconciled Cost Of Rev. Ann.
8.3%
4.3%
5.44.73.62.83.73.93.81.81.32.4--
Reconciled Depr. Ann.
-27.9%
-16.7%
0.50.60.91.21.61.91.51.51.20.70.10.1
Profit From Continuing Operations Ann.
-
-
-32.7-42.6-27.8-28.6-28.7-30.7-21.6-15.5-15.2-15-12.2-11.8
Normalized EBITDA Ann.
-
-
-36.7-38.6-35.9-26-26.9-28.7-16.6-13.2-13.2-13.2-11.4-9.7
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
50.5%
2Y CAGR
49.5%
3Y CAGR
33.9%
5Y CAGR
17.1%
7Y CAGR
35.7%
Total Revenue Annual growth is higher than historical averages.
Operating Exp. Ann.
1Y CHG
31.4%
2Y CAGR
26.4%
3Y CAGR
17.4%
5Y CAGR
18.8%
7Y CAGR
19.2%
10Y CAGR
20.6%
Operating Expenses Annual Cr growth is higher than historical averages.

Profound Medical Corp balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Total Shareholders Fund Profound Medical Corp Dec-2025 Total Shareholders Fund is $66 Million which is growth of 10.0% YoY.

  • POSITIVE

    Total Assets Profound Medical Corp Dec-2025 Total Assets is $77 Million which is growth of 10.3% YoY.

Profound Medical Corp, Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
⌄
6.4%
-5.8%
77.570.243.964.486.8104.629.934.222.217.615.3
⌄
-3.9%
8.5%
119.812.712.46.27.315.614.610.96.65.2
⌄
8.5%
-7.4%
66.460.431.25280.697.414.319.611.31110.1
Total Capitalization Ann.
6.5%
-6.2%
70.963.436.258.780.697.419.427.311.613.814.1
Tangible Assets Ann.
8.9%
-6.5%
66.360.230.751.376.592.89.314.14.510.810
Working Capital Ann.
6.6%
-5.5%
7062.535.557.87392.914.522.15.51314.2
Invested Capital Ann.
6.2%
-6.2%
70.965.138.359.280.697.423.428.315.31614.3
Tangible Book Value Ann.
8.9%
-6.5%
66.360.230.751.376.592.89.314.14.510.810
Borrowings Ann.
-16.9%
22.6%
4.75.17.98.21.41.710.98.84.14.94.2
Net Debt Ann.
-
-
-----------
Share Issued Ann.
20.2%
12.4%
36.33021.420.920.820.211.910.87.35.54
Number Of Shares End
13.6%
9.2%
30.625.821.320.920.819.711.910.87.34.84
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Assets Ann.
1Y CHG
10.4%
2Y CAGR
32.9%
3Y CAGR
6.4%
5Y CAGR
-5.8%
7Y CAGR
12.4%
10Y CAGR
17.6%
Total Assets Annual growth is stable compared to historical averages.
Total Current Liabilities Ann.
1Y CHG
-7.6%
2Y CAGR
-2.4%
3Y CAGR
13.2%
5Y CAGR
4.9%
7Y CAGR
0.7%
10Y CAGR
21.1%
Total Current Liabilities Annual Cr is falling faster than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
9.9%
2Y CAGR
45.9%
3Y CAGR
8.5%
5Y CAGR
-7.4%
7Y CAGR
19%
10Y CAGR
20.7%
Total ShareHolders Funds Annual growth is stable compared to historical averages.

Profound Medical Corp ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Book Value Per Share Profound Medical Corp Book Value Per Share is $1 which is growth of -32.2% YoY.

  • NEUTRAL

    ROE Profound Medical Corp ROE is 0% which is growth of 0% YoY.

Profound Medical Corp, Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
RoA Ann. %
-
-
--48.74%-52.74%-37.92%-32.08%-32.15%-48.26%-54.11%-75.22%-73.85%-140.99%
ROE Ann. %
-
-
--60.73%-68.69%-43.23%-34.50%-38.74%-91.37%-99.01%-134.34%-115.14%-206.48%
ROIC %
-
-
--10.4-23.9-15.8-12-7.8-14.8-9.4-19.4-29.6-10.7
OPM Ann. %
-
-
-256.27%-309.57%-397.50%-443.08%-440.72%-258.26%-357.63%-776.04%-359.49%--
Inventory Turnover Ratio Ann.
-
-
-0.60.40.50.60.90.60.73.3--
Asset Turnover Ann. %
-
-
-0.20.10.10.10.10.10.10.2--
Working Capital Turnover Ann.
26%
14.9%
0.20.20.20.10.10.10.30.10.7
Quick Ratio Ann.
-
-
-9.45.312.616.5192.24.31.54.316.4
Current Ratio Ann.
-
-
-10.56.614.818.620.32.84.81.64.516.5
Interest Coverage Ratio Ann.
-
-
---36.3-162.1-455.6-38.7-13.6-19-12.9-18.7-2
LT Debt To Equity Ann.
-
-
-0.10.20.1000.50.400.30.4
*All financials are in USD Million and price data in USD
Add metric to table
Search...

Profound Medical Corp cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Cash From Operating Activity Profound Medical Corp Dec-2025 Cash From Operating Activity is $-38 Million which is growth of -62.9% YoY.

  • NEUTRAL

    Net Cash Flow Profound Medical Corp Dec-2025 Net Cash Flow is $3 Million which is growth of 0% YoY.

Profound Medical Corp, Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
⌄
-
-
-38.2-23.5-22.3-25.8-22.4-20.6-15.3-13.4-11.8-10.8-4.9
⌄
-
-
-0.2---0.6-0.4-0.2-0.86.6-6.5
⌄
80.4%
-14%
41.154.71.57687.46.827.84.911.818.7
Cash Plus Cash Eqv. End Of Year Ann.
8.7%
-6.6%
59.754.926.246.567.283.914.722.58.815.57.6
Net Increase In Cash Plus Cash Eqv.s Ann.
-
-47.3%
2.731.2-20.8-18.8-1766.5-8.814.4-7.77.77.3
Cash Plus Cash Eqv. Begin Of Year Ann.
-6.5%
30%
54.926.246.567.283.914.823.58.216.67.80.3
Income Tax Paid Supplemental Data Ann.
-
-
--0.2--------
Interest Paid Supplemental Data Ann.
-
-
--0.7--------
Capex Ann.
-
-
-0.2----0.6-0.4-0.2--0.4-0.8-0.1
Issuance Of Capital Stock Ann.
-
-13.1%
42.462.1--85.58.825.381317.3
Issuance Of Debt Ann.
-
-
--7.3---9.2-4
Repayment Of Debt Ann.
-
-
-0.3-2.6-1.2-0.4-0.4-9.6-1.3-4.3-2.3-0.2-0.6
Repurchase Of Capital Stock Ann.
-
-
-----------
Free Cash Flow Ann.
-
-
-38.5-23.5-22.3-25.8-23-20.9-15.3-14.1-11.8-11.8-5.5
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Cash from Financing Act. Ann.
1Y CHG
-24.9%
2Y CAGR
423.5%
3Y CAGR
80.4%
5Y CAGR
-14%
7Y CAGR
5.7%
10Y CAGR
8.2%
Cash from Financing Annual Activity is falling faster than historical averages.
×